Delivery Order SPE2DB24D9238-SPE2DB24FDQPU

Award Date 9/24/24
Potential Completion Date 10/16/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BOTOX 100 Unit Vials to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $87,966.00 and a completion date of October 14, 2022. It is part of a larger indefinite delivery contract (IDC)...
This federal contract award is for the delivery of Botox 200 unit vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award has a ceiling value of $63,566.00 and is a firm fixed-price delivery order with no set-aside designation. The contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
This federal contract award is for the delivery of BOTOX 100 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency, under a firm fixed-price delivery order. The contract, valued at $46,148.00, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a total potential...
This federal contract award is for the delivery of BOTOX 100 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $88,144.00 and is a firm fixed-price delivery order with no set-aside designation. This award is part of DMS Pharmaceutical Group's broader contractual relationship...
This federal contract award is for the delivery of BOTOX 100 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $48,569.85 and an ultimate completion date of April 15, 2025. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group...
This federal contract award, valued at $4,614.80, was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical supplier based in Park Ridge, Illinois. The contract is for the delivery of BOTOX 100 unit vials, with an ultimate completion date of April 22, 2024. This award appears to be a delivery order issued under a larger indefinite delivery vehicle (IDV) contract, contract # SPE2DB, that DMS Pharmaceutical...
This federal contract award by the Defense Logistics Agency (DLA) is for the delivery of BOTOX 100 unit vials to the Department of Defense (DoD). The contract, which is a firm fixed-price delivery order, has a ceiling value of $4,614.80 and an ultimate completion date of October 11, 2024. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract is not set aside and is part of a larger indefinite...
This federal contract award is for the delivery of BOTOX 100 unit vials to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The award, valued at $8,814.40, was made to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the...
This contract award is for the delivery of BOTOX 100 UNIT VIALS to the Defense Logistics Agency (DLA), a civilian agency that supports the Department of Defense. The contract, valued at $11,537.00, is a delivery order awarded to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a firm fixed price pricing type and an ultimate completion date of April 8, 2024. This order is part of a larger indefinite delivery vehicle...
This federal contract award is for the delivery of BOTOX 100 unit vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order with a ceiling value of $5,481.60. It is not associated with a set-aside program. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with DLA...
  • SPE2DB24D9238
    Indefinite Delivery Contract
  • SPE2DB24D9238-SPE2DB24FDQPU
    Delivery Order

This federal contract award is for the delivery of BOTOX 100 unit vials to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $23,074.00, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This award is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract has no set-aside designation.

Generated 12/24/24, 9:31 AM